Minke A.E. Rab
Utrecht University(NL)Heidelberg University(DE)Erasmus MC(NL)University Hospital Heidelberg(DE)University Medical Center Utrecht(NL)University Medical Center Utrecht(NL)Erasmus MC Cancer Institute(NL)Erasmus University Rotterdam(NL)
Publications by Year
Research Areas
Hemoglobinopathies and Related Disorders, Erythrocyte Function and Pathophysiology, Blood groups and transfusion, Iron Metabolism and Disorders, Blood properties and coagulation
Most-Cited Works
- → AG-348 (Mitapivat), an allosteric activator of red blood cell pyruvate kinase, increases enzymatic activity, protein stability, and ATP levels over a broad range of PKLR genotypes(2020)75 cited
- → Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patients(2019)69 cited
- → Density, heterogeneity and deformability of red cells as markers of clinical severity in hereditary spherocytosis(2019)55 cited
- → Decreased activity and stability of pyruvate kinase in sickle cell disease: a novel target for mitapivat therapy(2021)43 cited
- → Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in sickle cell disease: A phase 2, open‐label study(2022)41 cited
- → PIEZO1 gain-of-function mutations delay reticulocyte maturation in hereditary xerocytosis(2019)31 cited